- Home
- OKE vs SNN Comparison
OKE vs SNN Comparison
Compare OKE & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OKE | SNN |
|---|---|---|
| Founded | 1906 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.8B | 14.0B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | OKE | SNN |
|---|---|---|
| Price | $71.10 | $32.23 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 4 |
| Target Price | ★ $91.14 | $32.83 |
| AVG Volume (30 Days) | ★ 4.4M | 497.0K |
| Earning Date | 10-28-2025 | 03-02-2026 |
| Dividend Yield | ★ 5.60% | 2.24% |
| EPS Growth | 13.61 | ★ 59.91 |
| EPS | ★ 5.43 | 0.56 |
| Revenue | ★ $31,564,000,000.00 | $5,944,000,000.00 |
| Revenue This Year | $51.00 | $7.78 |
| Revenue Next Year | $6.72 | $5.13 |
| P/E Ratio | ★ $13.56 | $28.10 |
| Revenue Growth | ★ 58.35 | 5.35 |
| 52 Week Low | $64.02 | $23.69 |
| 52 Week High | $111.02 | $38.79 |
Technical Indicators
Market Signals| Indicator | OKE | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 44.83 | 38.97 |
| Support Level | $73.28 | $32.06 |
| Resistance Level | $76.85 | $33.60 |
| Average True Range (ATR) | 1.40 | 0.41 |
| MACD | -0.30 | 0.03 |
| Stochastic Oscillator | 2.79 | 9.19 |
Price Performance
Historical ComparisonAbout OKE ONEOK Inc.
Oneok is a diversified midstream service provider specializing in natural gas gathering, processing, storage, and transportation and natural gas liquids transportation and fractionation. It also operates a refined product and crude oil segment connecting producers, refiners, and consumers. Operations are in the midcontinent, Permian, and Rocky Mountain regions.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.